黑色素瘤表面的石坑促进了瘤免疫相互作用,并证明了人类对检查点封锁的病理反应
Aya Ludin1,2,3, Georgia L Stirtz1,3, Asaf Tal1
1Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA.
bioRxiv : the preprint server for biology
|September 30, 2024
概括
研究人员在黑色素瘤瘤中发现了独特的"石坑",这些石坑对于免疫治疗的成功至关重要. 这些富含B2M的口袋吸引了CD8+T细胞,增强了癌细胞的杀死,并预测了治疗反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 斑马鱼模型 斑马鱼模型
背景情况:
- 免疫疗法可以克服瘤免疫抑制以消除癌症.
- 识别在癌症治疗期间促进免疫反应的机制至关重要.
研究的目的:
- 识别新的瘤微环境领域,以促进免疫疗法期间的免疫反应.
- 研究这些域在斑马鱼和人类黑色素瘤中的作用.
主要方法:
- 在斑马鱼中延长长期体外成像.
- 内源性黑色素瘤的高分辨率空间转录组学.
- 人类黑色素瘤样本的多重成像.
主要成果:
- 在黑色素瘤边缘发现了形口袋,富含β-2微球蛋白 (B2M) 和抗原识别分子.
- 这些石坑是CD8+ T细胞密度最高的石坑,促进了长时间的抗原识别.
- 在免疫刺激治疗后,石坑扩大,成为T细胞积累和瘤杀伤的关键地点,依赖于B2M.
- 在人类黑色素瘤中,坑的存在预测了对免疫检查点阻塞 (ICB) 治疗的反应,超过了T细胞透指标.
结论:
- 黑色素瘤坑是促进免疫治疗期间抗瘤免疫反应的关键领域.
- 石坑作为一种潜在的诊断工具,可以预测免疫治疗的成功.
- 准石坑可能会增强免疫检查点阻塞疗法的有效性.
更多相关视频
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
11.4K
07:41A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.4K
相关概念视频
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Cytotoxic T Cells-mediated Immune Response
857
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
857
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
